AI SCIENCE
Ever heard of medicine design?
The UK Government’s Sovereign AI Fund has invested in Isomorphic Labs, a London-based company using AI to help design new medicines.
The investment is part of a wider funding round announced on 12 May 2026.
Isomorphic Labs is working on AI tools that could help speed up drug discovery and support research into serious diseases.
The company was founded by Sir Demis Hassabis, the Nobel Prize-winning AI researcher behind DeepMind.
Its work builds on AlphaFold, the DeepMind AI system known for predicting protein structures, which was a major breakthrough in science.
In brief:
Isomorphic Labs has received backing from the UK Government’s Sovereign AI Fund.
The company uses AI to help design and develop new medicines.
The fund is focused on helping UK AI companies grow from Britain.
Brits are calling dibs
Isomorphic Labs is now developing its own AI models to help design different types of medicines across several disease areas.
Sovereign AI launched last month to support promising UK AI companies.
The fund aims to help British AI firms grow, compete globally, and keep more jobs and innovation in the UK.
So far, three startups have received equity investment from Sovereign AI, while nine have received support overall, including access to compute.
We always like a win for the UK. -MV